Psychosis is a relatively common mental health condition, affecting 2-3% of the population at some point in the lifespan, in which perception and thoughts become altered. However, non-clinical psychotic experiences (PEs) have been reported at even greater rates in the general population. Although PEs are often viewed as a precursor to psychotic illness, individuals who […]
Archives for 2017
Immunopsychiatry offers insights into treatment of depression and psychosis
When we think of the immune system, we typically envision a system devoted to protecting our bodies from disease. This system innately responds to pathogens with first-line defense mechanisms, such as chemical barriers or inflammation. Over time, a healthy immune system will adapt to pathogens and activate a more specific response to each one, which […]
Early functional imaging changes found in those at risk of Alzheimer’s disease
Alzheimer’s disease (AD) is a neurological condition that most commonly affects people over 65. It causes a range of symptoms including memory loss, confusion, problems with movement and even personality changes. AD can be incredibly distressing for both the patient and their families, and it is thought to affect over 800 000 people in the UK. […]
PhD retrospective with Sally Jennings
We would like to congratulate Dr. Sally Jennings who recently completed her PhD, which was supervised by Dr Howard Ring and Prof Tony Holland at the Cambridge Intellectual and Developmental Disabilities Research Group (CIDDRG). We caught up with Sally to ask her about her research into neural predictors of cognitive decline in Down’s Syndrome. Can you give […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 8
- Next Page »